人工智能辅助诊断方法用于胰腺导管腺癌早期检测的综述研究
本文综述胰腺导管腺癌(PDAC)早期检测,涵盖分子生物学与生物标志物、肿瘤免疫微环境、传统与非传统影像技术(超声内镜、多排CT、CT纹理分析、PET-CT、MRI、扩散加权成像、胰腺癌次要征象及分子影像),以及人工智能在PDAC检测与预后中的应用。综述结论认为,基于MRI图像的人工智能辅助诊断方法未来有望提高检测的敏感度与特异度,并更准确地对恶性PDAC进行分类。
要点
- PDAC常在晚期才被发现,仅约四分之一患者具有可切除肿瘤,早期检测可改善生存。
- 综述涵盖超声内镜、多排CT、CT纹理分析、PET-CT、MRI、扩散加权成像及分子影像等检测手段。
- 综述结论认为基于MRI图像的人工智能辅助诊断方法未来有望提高敏感度与特异度并更准确分类恶性PDAC。
核心结论
- 综述结论认为,基于MRI图像的人工智能辅助诊断方法未来有望提高检测的敏感度与特异度,并更准确地对恶性PDAC进行分类。
研究设计与样本
- 综述类文章,检索范围与纳入文献数量原文未报告,文中汇总了PDAC早期检测相关的分子生物学、生物标志物、影像技术及人工智能应用。
局限性
- 原文结论将基于MRI图像的人工智能辅助诊断方法定位为未来可提出的方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive, chemo-refractory and recalcitrant cancer and increases the number of deaths. With just around 1 in 4 individuals having respectable tumours, PDAC is frequently discovered when it is in an advanced stage. Accordingly, ED of PDAC improves patient survival. Subsequently, this paper reviews the early detection of PDAC, initially, the work presented an overview of PDAC. Subsequently, it reviews the molecular biology of pancreatic cancer and the development of molecular biomarkers are represented. This article illustrates the importance of identifying PDCA, the Immune Microenvironment of Pancreatic Cancer. Consequently, in this review, traditional and non-traditional imaging techniques are elucidated, traditional and non-traditional methods like endoscopic ultrasound, Multidetector CT, CT texture analysis, PET-CT, magnetic resonance imaging, diffusion-weighted imaging, secondary signs of pancreatic cancer, and molecular imaging. The use of artificial intelligence in pancreatic cancer, novel MRI techniques, and the future directions of AI for PDAC detection and prognosis is then described. Additionally, the research problem definition and motivation, current trends and developments, state of art of survey, and objective of the research are demonstrated in the review. Consequently, this review concluded that Artificial Intelligence Assisted Diagnostic Methods with MRI images can be proposed in future to improve the specificity and the sensitivity of the work, and to classify malignant PDAC with greater accuracy.
引用
- Sijithra PC, Santhi N, Ramasamy N, et al. A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods. Eur J Radiol. 2023. PMID: 37454557. doi:10.1016/j.ejrad.2023.110972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。